Clinical Trials Directory

Trials / Completed

CompletedNCT03617419

Vscan Access R2 Feasibility Evaluation

Evaluation of Feasibility and Accuracy of Assisted Fetal Heart Rate (FHR) Feature of the GE Vscan Access R2 Ultrasound System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
GE Healthcare · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.

Detailed description

This study is being done to evaluate whether the Vscan Access R2 Ultrasound System Assisted FHR phantom testing conclusions can be extrapolated onto human fetal heart rate measurements, where CTG (GE Corometrics 170 Series Fetal Monitor) is to provide a reference value. It should be noted that the Vscan Access R2 Ultrasound System with Assisted FHR has a different intended use than CTG (momentary FHR value versus continuous monitoring of FHR patterns and trends) and this aspect is out of scope of this research. Usability data will be gathered for further user experience optimization.

Conditions

Interventions

TypeNameDescription
DEVICEGE VScan Access R2 Ultrasound SystemA diagnostic ultrasound imaging system manufactured by the study Sponsor.
DEVICEGE Corometrics 170 Series Fetal MonitorA reference device to record a continuous fetal heart rate.
DEVICEGE Corometrics 170 Series Fetal MonitorA reference device for verification of scanning the fetal heart.

Timeline

Start date
2017-11-14
Primary completion
2017-11-20
Completion
2018-02-26
First posted
2018-08-06
Last updated
2019-07-11
Results posted
2019-07-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03617419. Inclusion in this directory is not an endorsement.

Vscan Access R2 Feasibility Evaluation (NCT03617419) · Clinical Trials Directory